8-K Announcements
6May 4, 2026·SEC
Feb 25, 2026·SEC
Feb 20, 2026·SEC
Loews Corporation (L) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Loews Corporation (L) stock price & volume — 10-year historical chart
Loews Corporation (L) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Loews Corporation (L) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 4, 2026 | $1.63 | $4.6B |
| Q1 2026 | Feb 9, 2026 | $1.94 | $4.7B |
| Q4 2025 | Nov 3, 2025 | $2.43 | $4.6B |
| Q3 2025 | Aug 4, 2025 | $1.87 | $4.5B |
Loews Corporation (L) competitors in Commercial lines and surety insurers — business model, growth, and fundamentals comparison
Loews Corporation (L) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Loews Corporation (L) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.73B | 14.04B | 14.73B | 13.67B | 13.73B | 14.05B | 15.68B | 17.24B | 18.18B | 18.29B |
| Revenue Growth % | 4.81% | 2.25% | 4.86% | -7.2% | 0.44% | 2.35% | 11.59% | 9.96% | 5.44% | 4.53% |
| Medical Costs & Claims | 6.54B | 6.91B | 7.19B | 7.58B | 7.81B | 8.14B | 8.71B | 9.54B | 10.19B | 9.87B |
| Medical Cost Ratio % | 47.64% | 49.18% | 48.82% | 55.46% | 56.92% | 57.96% | 55.57% | 55.32% | 56.07% | 53.95% |
| Gross Profit | 7.19B▲ 0% | 7.14B▼ 0.8% | 7.54B▲ 5.6% | 6.09B▼ 19.2% | 5.91B▼ 2.9% | 5.91B▼ 0.1% | 6.97B▲ 17.9% | 7.7B▲ 10.6% | 7.98B▲ 3.6% | 8.42B▲ 0% |
| Gross Margin % | 52.36% | 50.82% | 51.18% | 44.54% | 43.08% | 42.04% | 44.43% | 44.68% | 43.93% | 46.05% |
| Gross Profit Growth % | 9.18% | -0.76% | 5.62% | -19.25% | -2.86% | -0.1% | 17.93% | 10.58% | 3.65% | - |
| Operating Expenses | 5.61B | 6.3B | 6.42B | 7.55B | 3.75B | 4.79B | 4.97B | 5.83B | 5.7B | 6.12B |
| OpEx / Revenue % | 40.84% | 44.88% | 43.59% | 55.25% | 27.34% | 34.11% | 31.7% | 33.81% | 31.37% | 33.43% |
| Depreciation & Amortization | 874M | 912M | 943M | 734M | 515M | 509M | 538M | 583M | 610M | 0 |
| Combined Ratio % | 88.48% | 94.06% | 92.4% | 110.71% | 84.26% | 92.07% | 87.27% | 89.13% | 87.44% | 87.38% |
| Operating Income | 1.58B▲ 0% | 834M▼ 47.3% | 1.12B▲ 34.2% | -1.46B▼ 230.8% | 2.16B▲ 247.5% | 1.11B▼ 48.4% | 2B▲ 79.2% | 1.87B▼ 6.1% | 2.28B▲ 21.8% | 2.31B▲ 0% |
| Operating Margin % | 11.52% | 5.94% | 7.6% | -10.71% | 15.74% | 7.93% | 12.73% | 10.87% | 12.56% | 12.62% |
| Operating Income Growth % | 69.02% | -47.28% | 34.17% | -230.83% | 247.54% | -48.43% | 79.17% | -6.11% | 21.82% | - |
| EBITDA | 2.46B | 1.75B | 2.06B | -730M | 2.67B | 1.62B | 2.53B | 2.46B | 2.89B | 2.64B |
| EBITDA Margin % | 17.88% | 12.43% | 14% | -5.34% | 19.49% | 11.55% | 16.16% | 14.25% | 15.92% | 14.43% |
| Interest Expense | 646M | 574M | 591M | 515M | 424M | 378M | 376M | 441M | 437M | 445M |
| Non-Operating Income | -646M | -574M | -591M | -515M | -424M | -378M | -376M | -441M | -437M | -332M |
| Pretax Income | 1.58B▲ 0% | 834M▼ 47.3% | 1.12B▲ 34.2% | -1.46B▼ 230.8% | 2.16B▲ 247.5% | 1.11B▼ 48.4% | 2B▲ 79.2% | 1.87B▼ 6.1% | 2.28B▲ 21.8% | 2.23B▲ 0% |
| Pretax Margin % | 11.52% | 5.94% | 7.6% | -10.71% | 15.74% | 7.93% | 12.73% | 10.87% | 12.56% | 12.2% |
| Income Tax | 170M | 128M | 248M | -173M | 475M | 223M | 451M | 380M | 511M | 280M |
| Effective Tax Rate % | 10.75% | 15.35% | 22.16% | 11.82% | 21.99% | 20.02% | 22.6% | 20.28% | 22.38% | 12.54% |
| Net Income | 1.16B▲ 0% | 636M▼ 45.4% | 932M▲ 46.5% | -931M▼ 199.9% | 1.56B▲ 267.8% | 822M▼ 47.4% | 1.43B▲ 74.5% | 1.41B▼ 1.4% | 1.67B▲ 17.9% | 1.87B▲ 0% |
| Net Margin % | 8.47% | 4.53% | 6.33% | -6.81% | 11.38% | 5.85% | 9.15% | 8.2% | 9.17% | 10.22% |
| Net Income Growth % | 77.98% | -45.36% | 46.54% | -199.89% | 267.78% | -47.38% | 74.45% | -1.39% | 17.89% | 40.84% |
| EPS (Diluted) | 3.45▲ 0% | 1.99▼ 42.3% | 3.07▲ 54.3% | -3.32▼ 208.1% | 6.00▲ 280.7% | 3.38▼ 43.7% | 6.29▲ 86.1% | 6.41▲ 1.9% | 7.97▲ 24.3% | 9.06▲ 0% |
| EPS Growth % | 78.76% | -42.32% | 54.27% | -208.14% | 280.72% | -43.67% | 86.09% | 1.91% | 24.34% | 28.9% |
| EPS (Basic) | 3.46 | 1.99 | 3.08 | -3.32 | 6.02 | 3.39 | 6.30 | 6.42 | 7.97 | - |
| Diluted Shares Outstanding | 337.5M | 319.93M | 303.35M | 280.32M | 260.2M | 243.28M | 227.81M | 220.53M | 209.1M | 206.27M |
Loews Corporation (L) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 79.59B | 78.32B | 82.24B | 80.24B | 81.63B | 75.57B | 79.2B | 81.94B | 86.35B | 85.65B |
| Asset Growth % | 3.91% | -1.6% | 5.01% | -2.44% | 1.73% | -7.42% | 4.8% | 3.47% | 5.38% | 15.63% |
| Total Investment Assets | 52.23B | 48.19B | 51.25B | 53.84B | 102.08B | 46.77B | 53.73B | 51.13B | 55.38B | 4M |
| Long-Term Investments | 51.28B | 47.28B | 50.18B | 52.68B | 52.85B | 4.22B | 48.25B | 44.01B | 47.31B | 188.91B |
| Short-Term Investments | 46.13B | 43.41B | 46.81B | 49.28B | 49.23B | 42.55B | 5.49B | 7.13B | 8.07B | 5.27B |
| Total Current Assets | 0 | 0 | 0 | 0 | 58.75B | 52.49B | 15.1B | 18.18B | 19.54B | 17.11B |
| Cash & Equivalents | 472M | 405M | 336M | 478M | 621M | 532M | 399M | 541M | 495M | 843M |
| Receivables | 7.2B | 7.57B | 7.28B | 7.45B | 8.9B | 9.4B | 9.21B | 10.51B | 10.98B | 44.26B |
| Other Current Assets | -53.8B | -51.38B | -54.43B | -57.21B | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 1.3B | 1.28B | 1.41B | 1.4B | 458M | 1.26B | 498M | 1.31B | 1.33B | 4.39B |
| Goodwill | 659M | 665M | 767M | 785M | 349M | 346M | 347M | 347M | 349M | 348M |
| Intangible Assets | 638M | 611M | 647M | 610M | 109M | 917M | 151M | 959M | 986M | 0 |
| PP&E (Net) | 15.43B | 15.51B | 15.57B | 10.45B | 9.89B | 10.03B | 10.72B | 10.74B | 10.7B | 10.78B |
| Other Assets | -68B | -64.07B | -67.16B | -64.53B | -40.32B | 7.57B | 4.63B | 7.71B | 7.47B | 8.3B |
| Total Liabilities | 55.02B | 56.93B | 60.31B | 61.05B | 62.45B | 60.37B | 62.67B | 64.01B | 66.71B | 66.06B |
| Total Debt | 11.53B | 11.38B | 11.53B | 10.11B | 9.08B | 9.02B | 9B | 8.94B | 9.49B | 8.93B |
| Net Debt | 11.06B | 10.97B | 11.2B | 9.63B | 8.46B | 8.49B | 8.6B | 8.4B | 8.99B | 8.09B |
| Long-Term Debt | 11.25B | 11.36B | 11.46B | 10.07B | 8.99B | 8.16B | 7.92B | 8.94B | 8.44B | 8.93B |
| Short-Term Debt | 280M | 17M | 77M | 37M | 93M | 854M | 1.08B | 5M | 1.05B | 1M |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 183M | 34.44B | 1.16B | 37.52B | 40.32B | 47.98B |
| Accounts Payable | 60M | 42M | 108M | 92M | 90M | 133M | 79M | 110M | 53M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 6.37B | 0 | 7.35B | 7.63B | 0 |
| Other Current Liabilities | -340M | -59M | -185M | -129M | 0 | 27.08B | 0 | 30.06B | 31.58B | 47.77B |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 3.1B |
| Other Liabilities | -12.97B | -15.6B | -16.4B | -15.16B | 47.7B | 12.81B | 48.5B | 12.47B | 12.98B | 4.38B |
| Total Equity | 24.57B▲ 0% | 21.39B▼ 12.9% | 21.93B▲ 2.5% | 19.18B▼ 12.5% | 19.18B▼ 0.0% | 15.2B▼ 20.7% | 16.52B▲ 8.7% | 17.94B▲ 8.5% | 19.64B▲ 9.5% | 19.59B▲ 0% |
| Equity Growth % | 5.16% | -12.94% | 2.54% | -12.54% | -0.03% | -20.72% | 8.71% | 8.54% | 9.5% | 30.38% |
| Shareholders Equity | 19.2B | 18.52B | 19.12B | 17.86B | 17.85B | 14.35B | 15.7B | 17.07B | 18.69B | 18.7B |
| Minority Interest | 5.36B | 2.87B | 2.81B | 1.32B | 1.33B | 852M | 821M | 871M | 955M | 887M |
| Retained Earnings | 16.1B | 15.77B | 15.82B | 14.15B | 14.78B | 14.93B | 15.62B | 16.46B | 17.38B | 17.7B |
| Common Stock | 3M | 3M | 3M | 3M | 2M | 2M | 2M | 2M | 2M | 2M |
| Accumulated OCI | -26M | -880M | -68M | 581M | 186M | -3.32B | -2.5B | -1.87B | -1.07B | -1.3B |
| Return on Equity (ROE) | 4.86% | 2.77% | 4.3% | -4.53% | 8.14% | 4.78% | 9.04% | 8.21% | 8.87% | 9.73% |
| Return on Assets (ROA) | 1.49% | 0.81% | 1.16% | -1.15% | 1.93% | 1.05% | 1.85% | 1.75% | 1.98% | 2.18% |
| Equity / Assets | 30.87% | 27.31% | 26.66% | 23.91% | 23.49% | 20.12% | 20.87% | 21.89% | 22.75% | 22.87% |
| Debt / Equity | 0.47x | 0.53x | 0.53x | 0.53x | 0.47x | 0.59x | 0.54x | 0.50x | 0.48x | 0.48x |
| Book Value per Share | 72.79 | 66.85 | 72.29 | 68.43 | 73.69 | 62.48 | 72.54 | 81.34 | 93.93 | 94.98 |
| Tangible BV per Share | 68.95 | 62.86 | 67.63 | 63.45 | 71.93 | 57.29 | 70.35 | 75.41 | 87.55 | 93.29 |
Loews Corporation (L) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 2.59B | 4.22B | 1.74B | 1.75B | 2.62B | 3.31B | 3.91B | 3.02B | 3.28B | 3.28B |
| Operating CF Growth % | 14.96% | 63.01% | -58.76% | 0.23% | 50.32% | 26.34% | 17.89% | -22.57% | 8.4% | -100.45% |
| Operating CF / Revenue % | 18.86% | 30.06% | 11.82% | 12.77% | 19.11% | 23.59% | 24.92% | 17.55% | 18.04% | 17.92% |
| Net Income | 1.41B | 706M | 871M | -1.29B | 1.69B | 891M | 1.54B | 1.49B | 1.77B | 1.87B |
| Depreciation & Amortization | 874M | 912M | 943M | 734M | 515M | 509M | 538M | 583M | 610M | -108M |
| Stock-Based Compensation | 0 | 35M | 0 | 0 | 0 | 0 | 36M | 0 | 0 | 0 |
| Deferred Taxes | -47M | 86M | 70M | -235M | 209M | -50M | 127M | -45M | 112M | 0 |
| Other Non-Cash Items | 133M | 640M | 68M | 2.15B | -712M | 396M | -47M | -87M | 4M | 784M |
| Working Capital Changes | 218M | 1.84B | -211M | 385M | 926M | 1.57B | 1.71B | 1.08B | 781M | 404M |
| Cash from Investing | -2.65B | -1.44B | -671M | -1.41B | -1.19B | -2.35B | -2.75B | -1.98B | -2.83B | -1.63B |
| Capital Expenditures | -1.03B | -995M | -1.04B | -710M | -482M | -660M | -686M | -632M | -579M | -618M |
| Acquisitions | -1.14B | -37M | 427M | -58M | 364M | -150M | -603M | -214M | -344M | -145M |
| Purchase of Investments | -9.06B | -11.38B | -8.66B | -10.72B | -9.75B | -10.14B | -6.99B | -6.83B | -8.63B | -2.75B |
| Sale/Maturity of Investments | 9.08B | 10.87B | 9.05B | 10.45B | 8.9B | 8.78B | 5.91B | 5.71B | 6.81B | 1.8B |
| Other Investing | -499M | 103M | -449M | -371M | -220M | -171M | -378M | -14M | -82M | 76M |
| Cash from Financing | 201M | -2.83B | -1.14B | -198M | -1.29B | -1.04B | -1.3B | -898M | -513M | -707M |
| Dividends Paid | -84M | -80M | -76M | -70M | -65M | -61M | -57M | -55M | -52M | -52M |
| Share Repurchases | -216M | -2.53B | -1.05B | -923M | -1.14B | -729M | -849M | -608M | -806M | -443M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K | 1000K | 0 |
| Other Financing | -155M | -47M | -137M | -138M | -94M | -180M | -294M | -163M | -187M | -153M |
| Net Change in Cash | 145M▲ 0% | -67M▼ 146.2% | -69M▼ 3.0% | 142M▲ 305.8% | 143M▲ 0.7% | -89M▼ 162.2% | -133M▼ 49.4% | 142M▲ 206.8% | -46M▼ 132.4% | 283M▲ 0% |
| Exchange Rate Effect | 9M | -10M | 5M | 9M | -4M | -19M | 5M | -10M | 16M | -182M |
| Cash at Beginning | 327M | 472M | 405M | 336M | 478M | 621M | 532M | 399M | 541M | 495M |
| Cash at End | 472M | 405M | 336M | 478M | 621M | 532M | 399M | 541M | 495M | 843M |
| Free Cash Flow | 1.56B▲ 0% | 3.23B▲ 107.0% | 700M▼ 78.3% | 1.03B▲ 47.9% | 2.14B▲ 106.9% | 2.65B▲ 24.0% | 3.22B▲ 21.4% | 2.39B▼ 25.7% | 2.7B▲ 12.8% | 2.18B▲ 0% |
| FCF Growth % | 94.15% | 106.99% | -78.31% | 47.86% | 106.86% | 23.96% | 21.36% | -25.71% | 12.83% | -27.01% |
| FCF Margin % | 11.35% | 22.98% | 4.75% | 7.57% | 15.6% | 18.89% | 20.54% | 13.88% | 14.85% | 11.94% |
| FCF per Share | 4.62 | 10.09 | 2.31 | 3.69 | 8.23 | 10.91 | 14.14 | 10.85 | 12.91 | 12.91 |
Loews Corporation (L) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 88.48% | 94.06% | 92.4% | 110.71% | 84.26% | 92.07% | 87.27% | 89.13% | 87.44% | 87.38% |
| Medical Cost Ratio | 47.64% | 49.18% | 48.82% | 55.46% | 56.92% | 57.96% | 55.57% | 55.32% | 56.07% | 53.95% |
| Return on Equity (ROE) | 4.86% | 2.77% | 4.3% | -4.53% | 8.14% | 4.78% | 9.04% | 8.21% | 8.87% | 9.73% |
| Return on Assets (ROA) | 1.49% | 0.81% | 1.16% | -1.15% | 1.93% | 1.05% | 1.85% | 1.75% | 1.98% | 2.18% |
| Equity / Assets | 30.87% | 27.31% | 26.66% | 23.91% | 23.49% | 20.12% | 20.87% | 21.89% | 22.75% | 22.87% |
| Book Value / Share | 72.79 | 66.85 | 72.29 | 68.43 | 73.69 | 62.48 | 72.54 | 81.34 | 93.93 | 94.98 |
| Debt / Equity | 0.47x | 0.53x | 0.53x | 0.53x | 0.47x | 0.59x | 0.54x | 0.50x | 0.48x | 0.48x |
| Revenue Growth | 4.81% | 2.25% | 4.86% | -7.2% | 0.44% | 2.35% | 11.59% | 9.96% | 5.44% | 4.53% |
Loews Corporation (L) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 4, 2026·SEC
Feb 25, 2026·SEC
Feb 20, 2026·SEC
Loews Corporation (L) stock FAQ — growth, dividends, profitability & financials explained
Loews Corporation (L) grew revenue by 5.4% over the past year. This is steady growth.
Yes, Loews Corporation (L) is profitable, generating $1.87B in net income for fiscal year 2025 (9.2% net margin).
Yes, Loews Corporation (L) pays a dividend with a yield of 0.24%. This makes it attractive for income-focused investors.
Loews Corporation (L) has a return on equity (ROE) of 8.9%. This is below average, suggesting room for improvement.
Loews Corporation (L) has a combined ratio of 87.4%. A ratio below 100% indicates underwriting profitability.
Loews Corporation (L) financial analysis — history, returns, DCA and operating performance tools
Analyst verdict, bull/bear case, risk factors and peer comparison
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates